Speech therapy for people with Parkinson's disease

Editorial

. 2024 Jul 10:386:q1254.

doi: 10.1136/bmj.q1254.

Affiliations

¹ School of Health and Rehabilitation Sciences, Faculty of Health Sciences, University of Queensland, Brisbane, QLD, Australia d.theodoros@uq.edu.au.
² Aberdeenshire, UK.

Editorial

Deborah Theodoros et al. BMJ. 2024.

. 2024 Jul 10:386:q1254.

doi: 10.1136/bmj.q1254.

¹ School of Health and Rehabilitation Sciences, Faculty of Health Sciences, University of Queensland, Brisbane, QLD, Australia d.theodoros@uq.edu.au.
² Aberdeenshire, UK.

No abstract available

Comment on

Lee Silverman voice treatment versus NHS speech and language therapy versus control for dysarthria in people with Parkinson's disease (PD COMM): pragmatic, UK based, multicentre, three arm, parallel group, unblinded, randomised controlled trial.
Sackley CM, Rick C, Brady MC, Woolley R, Burton C, Patel S, Masterson-Algar P, Nicoll A, Smith CH, Jowett S, Ives N, Beaton G, Dickson S, Ottridge R, Sharp L, Nankervis H, Clarke CE; PD COMM collaborative group. Sackley CM, et al. BMJ. 2024 Jul 10;386:e078341. doi: 10.1136/bmj-2023-078341. BMJ. 2024. PMID: 38986549 Free PMC article. Clinical Trial.